Journal article
Cardiac energetics in severe mitral regurgitation: relationship with eccentric hypertrophy, stroke volume, and effects of valve repair
- Abstract:
- Aims: Understanding changes in ATP metabolism may lead to improved risk stratification in severe primary mitral regurgitation (MR). Here, we seek to compare the energetic phenotype of volume-overload pathological hypertrophy with athletic hypertrophy and with the normal heart under catecholamine stress. Methods and results: Nineteen severe-MR patients underwent cardiac magnetic resonance and 31P-spectroscopy for energetics, including phosphocreatine to adenosine triphosphate ratio (PCr/ATP), the pseudo-first-order forward rate constant of the creatine kinase reaction (kf) and CK flux (kf × [PCr]). When compared with 20 healthy controls, severe MR was associated with lower PCr/ATP (1.58 ± 0.32 vs. 2.08 ± 0.28, P < 0.001). This is related to the severity of regurgitation (r −0.59, P < 0.001) but not to LVEF (r −0.20, P = 0.23) or LV systolic strain (P = 0.18). When compared to 17 athletes with similarly increased end-diastolic volume (athletes 107 ± 10 mL/m2 vs. 114 ± 22, P = 0.29), severe MR had greater total cardiac output (by 42%, P < 0.001), and lower PCr/ATP (by 28%, P < 0.001) and CK flux (by 41%, P = 0.04). When compared to normal hearts during dobutamine stress at matched cardiac output levels, median kf (by 45%, P = 0.08) and CK flux (by 53%, P = 0.02) were lower in severe MR. PCr/ATP increased (by 17%, P = 0.04) following mitral valve repair (MVR) in a subset of patients (n = 14, median 7 months). Seven patients during MVR and six patients without volume loading donated LV biopsy, revealing that creatine was not lower in severe MR. Conclusion: Even with normal LVEF, severe MR is associated with reduced PCr/ATP, CK kf, and CK flux. PCr/ATP reduction resolved with MVR. Thus, targeting CK capacity and/or flux may be a therapeutic strategy to prevent/treat systolic failure in MR.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 602.0KB, Terms of use)
-
- Publisher copy:
- 10.1093/ehjimp/qyaf146
Authors
+ NIHR Cambridge Biomedical Research Centre
More from this funder
- Funder identifier:
- https://ror.org/05m8dr349
- Publisher:
- Oxford University Press
- Journal:
- European Heart Journal - Imaging Methods and Practice More from this journal
- Volume:
- 3
- Issue:
- 4
- Pages:
- qyaf146
- Article number:
- qyaf146
- Publication date:
- 2025-11-25
- Acceptance date:
- 2025-10-27
- DOI:
- EISSN:
-
2755-9637
- ISSN:
-
2755-9637
- Language:
-
English
- Keywords:
- Pubs id:
-
2336344
- UUID:
-
uuid_82874781-0a9f-4489-839e-3135d7db1025
- Local pid:
-
pubs:2336344
- Source identifiers:
-
3560382
- Deposit date:
-
2025-12-12
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record